Eric Mou MD

PubMed

• 1 citations
  The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool.
  Matthew J Maurer, Susan K Parsons, Jenica N Upshaw, Angie Mae Rodday, Raphael Mwangi
  Blood Advances. 2025-03-25
• 1 citations
  Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting.
  Prajwal Dhakal, Mario Sy, Grerk Sutamtewagul, Eric Mou, Nanmeng Yu
  Journal of Immunotherapy and Precision Oncology. 2024-08-01
• Chimeric antigen receptor T-cell therapy for refractory post-transplant lymphoproliferative disorder after lung transplantation.
  Kaleb Veit, Tahuanty Peña, Julia Klesney-Tait, Eric Mou, Umar Farooq
  JHLT Open. 2024-08-01

Abstracts/Posters

• Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Mul...
  Eric Mou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
  Eric Mou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Characteristics and Financial Impact of Potentially Inappropriate Platelet Transfusion in the Inpatient Hospital Setting 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019